Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
What matters far more than the exact route is whether you needed the injection in the first place, and whether the dose and schedule are right
In clinical research settings, this difference matters most in how each compound is measured: Tesamorelin has been studied in trials involving GH and IGF-1 level changes, while AOD-9604 research has focused specifically on lipolysis and fat oxidation markers without the same IGF-1 elevation a distinction documented in peer-reviewed pharmacology literature comparing hGH fragments to full GHRH analogs
The compound specifically targeted visceral adipose tissue, the metabolically harmful deep abdominal fat associated with insulin resistance and cardiovascular disease
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
US$ 25.37
US$ 21.91
US$ 24.51
US$ 25.67
US$ 29.33
US$ 22.58
